ClinicalTrials.Veeva

Menu

Clinical Evaluation of the Safety and Efficacy of Yung Sheng 38% Color Contact Lens

Y

Yung Sheng Optical

Status

Completed

Conditions

Myopia

Treatments

Device: Soft Contact Lens

Study type

Interventional

Funder types

Industry

Identifiers

NCT06128473
CE-120901

Details and patient eligibility

About

This was a single group, open-label clinical study to assess the safety and efficacy of Yung Sheng 38% color contact lens for vision correction.

Enrollment

71 patients

Sex

All

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. The subject must sign the informed consent form.
  2. The subject must be at least 20 years of age as of the date of evaluation for the study.
  3. The subject must have a spherical prescription range between 0 to -12.00 diopters in each eye.
  4. The subject must have manifest refraction Snellen visual acuities (VA) less than 0.8 in each naked eye.
  5. The subject must have normal eyes, except ametropia.
  6. The subject must appear able and willing to adhere to the instructions set forth in this clinical protocol.
  7. The subject must appear able and willing to fill the daily card.

Exclusion criteria

  1. The subjects who need to use ophthalmic medicine for therapy.
  2. The subjects who have ocular or systemic allergies or disease that may interfere with contact lens wear.
  3. The subjects who have any history of ocular surgery/injury within 8 weeks prior to enrollment.
  4. The subjects who have clinically significant tear secretion abnormal.
  5. The subjects who enrolled in another contact lens clinical trial within 30 days prior to enrolment.

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

71 participants in 1 patient group

Yung Sheng 38% color contact lens
Experimental group
Treatment:
Device: Soft Contact Lens

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems